AUTH/3482/3/21 - Complainant v GlaxoSmithKline
Alleged promotion of Nucala (mepolizumab) on LinkedIn
-
Received04 March 2022
-
Case numberAUTH/3482/3/21
-
StatusNo breach, outwith the scope of the Code